Market revenue in 2024 | USD 4,366.3 million |
Market revenue in 2030 | USD 6,474.9 million |
Growth rate | 6.9% (CAGR from 2025 to 2030) |
Largest segment | Non-cold chain logistics |
Fastest growing segment | Cold Chain Logistics |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cold Chain Logistics, Non-cold Chain Logistics |
Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical third-party logistics market will help companies and investors design strategic landscapes.
Non-cold chain logistics was the largest segment with a revenue share of 83.14% in 2024. Horizon Databook has segmented the France biopharmaceutical third-party logistics market based on cold chain logistics, non-cold chain logistics covering the revenue growth of each sub-segment from 2018 to 2030.
France biopharmaceutical third party logistics market accounted for 16.9% share in 2020 in the European market. According to the World Bank, the Logistics Performance Index (LPI) score of France was 3.84 in 2018. Well-established transportation sector of France also provides strong platform for growth of biopharmaceutical third party logistics market.
For instance, according to OECD, 168,480 million tonnekm of freight transport was completed in the country in 2018. Capacity expansion by key players is likely to augment the growth of France biopharmaceutical third party logistics market.
Horizon Databook provides a detailed overview of country-level data and insights on the France biopharmaceutical third-party logistics market , including forecasts for subscribers. This country databook contains high-level insights into France biopharmaceutical third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account